Category Archives: business

New US government nano commercialization effort: nanosensors

The latest announcement (this one about nanosensors) from the US National Nanotechnology Coordination Office (NNCO) on behalf of the US National Nanotechnology (NNI) gets a little confusing but hopefully I’ve managed to clarify things.

It starts off simply enough, from a June 22, 2015 news item on Azonano,

The National Nanotechnology Coordination Office (NNCO) is pleased to announce the launch of a workshop report and a web portal, efforts coordinated through and in support of the Nanotechnology Signature Initiative ‘Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment’ (Sensors NSI). Together, these resources help pave the path forward for the development and commercialization of nanotechnology-enabled sensors and sensors for nanotechnology.

A June 19, 2015 NNCO news release on EurekAlert, which originated the news item, provides details about the report, the new portal, and the new series of webinars,

The workshop report is a summary of the National Nanotechnology Initiative (NNI)-sponsored event held September 11-12, 2014, entitled ‘Sensor Fabrication, Integration, and Commercialization Workshop.’ The goal of the workshop was to identify and discuss challenges that are faced by the sensor development community during the fabrication, integration, and commercialization of sensors, particularly those employing or addressing issues of nanoscale materials and technologies.

Workshop attendees, including sensor developers and representative from Federal agencies, identified ways to help facilitate the commercialization of nanosensors, which include:

  • Enhancing communication among researchers, developers, manufacturers, customers, and the Federal Government agencies that support and regulate sensor development.
  • Leveraging resources by building testbeds for sensor developers.
  • Improving access of university and private researchers to federally supported facilities.
  • Encouraging sensor developers to consider and prepare for market and regulatory requirements early in the development process.

In response to discussions at the workshop, the NNI has also launched an NSI Sensors web portal to share information on the sensors development landscape, including funding agencies and opportunities, federally supported facilities, regulatory guidance, and published standards. Ongoing dialogue and collaboration among various stakeholder groups will be critical to effectively transitioning nanosensors to market and to meeting the U.S. need for a reliable and robust sensor infrastructure.

On Thursday June 25, 2015, from noon to 1 pm EDT, NNCO will host a webinar to summarize the highlights from the 2014 ‘Sensor Fabrication, Integration, and Commercialization Workshop’ and to introduce the newly developed Sensors NSI Web Portal. The webinar will also feature a Q&A segment with members of the public. Questions for the panel can be submitted to webinar@nnco.nano.gov from June 18 through the end of the webinar at 1 pm EDT on June 25, 2015.

Here’s the portal for what they’ve called the NSI [Nanotechnology Signature Initiative]: Nanotechnology for Sensors and Sensors for Nanotechnology — Improving and Protecting, Health Safety, and the Environment, also known as, Sensors NSI Web Portal.

Here’s the report titled, “Sensor Fabrication, Integration, and Commercialization Workshop [2014].”

As for the first webinar in this new series, from the National Signature Webinar Series: Resources for the Development of Nanosensors webpage,

The National Nanotechnology Coordination Office (NNCO) will host a webinar to summarize the highlights from the September 2014 Sensor Fabrication, Integration, and Commercialization Workshop and to introduce the newly developed Sensors NSI Web Portal, which was created to share information on the sensors development landscape, including Federal program and funding opportunities, federally supported facilities, regulatory guidance, and published standards.

On Thursday, June 25, 2015, from 12 noon to 1 pm EDT, Federal panelists will begin the event with a discussion of the findings from the Sensor Fabrication, Integration, and Commercialization Workshop, as well as a demonstration of the resources available on the Sensors NSI Portal.  [emphasis mine]

Federal panelists at the event will include:

This event will feature a Q&A segment with members of the public. Questions for the panel can be submitted to webinar@nnco.nano.gov from June 18 through the end of the webinar at 1 pm on June 25, 2015. The moderator reserves the right to group similar questions and to omit questions that are either repetitive or not directly related to the topic. Due to time constraints, it may not be possible to answer all questions.

You can find the link to register at the end/bottom of the event page.

The NNCO does have one other Public Webinar series, ‘NNCO Small- and Medium-sized Business Enterprise (SME) Webinar Series’. They have archived previously held webinars in this series. There are no upcoming webinars in this series currently scheduled.

Abakan makes good on Alberta (Canada) promise (coating for better pipeline transport of oil)

It took three years but it seems that US company Abakan Inc.’s announcement of a joint research development centre at the Northern Alberta Institute of Technology (NAIT), (mentioned here in a May 7, 2012 post [US company, Abakan, wants to get in on the Canadian oils sands market]), has borne fruit. A June 8, 2015 news item on Azonano describes the latest developments,

Abakan Inc., an emerging leader in the advanced coatings and metal formulations markets, today announced that it has begun operations at its joint-development facility in Edmonton, Alberta.

Abakan’s subsidiary, MesoCoat Inc., along with the lead project partner, Northern Alberta Institute of Technology (NAIT) will embark on an 18-month collaborative effort to establish a prototype demonstration facility for developing, testing and commercializing wear-resistant clad pipe and components. Western Economic Diversification Canada is also supporting this initiative through a $1.5 million investment toward NAIT. Improvements in wear resistance are expected to make a significant impact in reducing maintenance and downtime costs while increasing productivity in oil sands and other mining applications.

A June 4, 2015 Abakan news release, which originated the news item, provides more detail about the proposed facility, the difficulties encountered during the setup, and some interesting information about pipes,

Abakan shipped its CermaClad high-speed large-area cladding system for installation at the Northern Alberta Institute of Technology’s (NAIT) campus in Edmonton, Alberta in early 2015. Despite delays associated with the installation of some interrelated equipment and machinery, the CermaClad system and other ancillary equipment are now installed at the Edmonton facility. The Edmonton facility is intended to serve as a pilot-scale wear-resistant clad pipe manufacturing facility for the development and qualification of wear-resistant clad pipes, and as a stepping stone for setting-up a full-scale wear-resistant clad pipe manufacturing facility in Alberta. The new facility will also serve as a platform for Abakan’s introduction to the Alberta oil sands market, which, with proven reserves estimated at more than 169 billion barrels, is one of the largest oil resources in the world and a major source of oil for Canada, the United States and Asia. Since Alberta oil sands production is expected to increase significantly over the next decade, producers want to extend the life of the carbon steel pipes used for the hydro-transportation of tailings with harder, tougher coatings that protect pipes from the abrasiveness of tar-like bituminous oil sands.

“Our aim is to fast-track market entry of our wear-resistant clad pipe products for the transportation of oil sands and mining slurries. We have received commitments from oil sands producers in Canada and mining companies in Mexico and Brazil to field-test CermaClad wear-resistant clad pipe products as soon as our system is ready for testing. Apart from our work with conventional less expensive chrome carbide and the more expensive tungsten carbide wear-resistant cladding on pipes, Abakan also expects to introduce new iron-based structurally amorphous metal (SAM) alloy cladding that in testing has exhibited better performance than tungsten carbide cladding, but at a fraction of the cost.” Robert Miller stated further that “although more expensive than the more widely used chrome carbide cladding, our new alloy cladding is expected to be a significantly better value proposition when you consider an estimated life of three times that of chrome carbide cladding and those cost efficiencies that correspond to less downtime revenue losses, and lower maintenance and replacement costs.”

The costs associated with downtime and maintenance in the Alberta oil sands industry estimated at more than $10 billion a year are expected to grow as production expands, according to the Materials and Reliability in Oil Sands (MARIOS) consortium in Alberta. The development of Alberta’s oil sands has been held up by the lack of materials for transport lines and components that are resistant to the highly abrasive slurry. Due to high abrasion, the pipelines have to be rotated every three to four months and replaced every 12 to 15 months. [emphasis mine] The costs involved just in rotating and replacing the pipes is approximately $2 billion annually. The same is true of large components, for example the steel teeth on the giant electric shovels used to recover oil sands, must be replaced approximately every two days.

Abakan’s combination of high productivity coating processes and groundbreaking materials are expected to facilitate significant efficiencies associated with the extraction of these oil resources. Our proprietary materials combined with CermaClad large-area based fusion cladding technology, have demonstrated in laboratory tests a three to eight times improvement in wear and corrosion resistance when compared with traditional weld overlays at costs comparable to rubber and metal matrix composite alternatives. Abakan intends to complete development and initiate field-testing by end of year 2016 and begin the construction of a full-scale wear-resistant clad pipe manufacturing facility in Alberta in early-2017.

Given that there is extensive talk about expanding oil pipelines from Alberta to British Columbia (where I live), the information about the wear and tear is fascinating and disturbing. Emotions are high with regard to the proposed increase in oil flow to the coast as can be seen in a May 27, 2015 article by Mike Howell for the Vancouver Courier about a city hall report on the matter,

A major oil spill in Vancouver waters could potentially expose up to one million people to unsafe levels of a toxic vapour released from diluted bitumen, city council heard Wednesday in a damning city staff report on Kinder Morgan’s proposal to build a pipeline from Alberta to Burnaby [British Columbia].

In presenting the report, deputy city manager Sadhu Johnston outlined scenarios where exposure to the chemical benzene could lead to adverse health effects for residents and visitors, ranging from dizziness to nausea to possible death.

“For folks that are on the seawall, they could be actually struck with this wave of toxic gases that could render them unable to evacuate,” said Johnston, noting 25,000 residents live within 300 metres of the city’s waterfront. “These are serious health impacts. So this is not just about oil hitting shorelines, this is about our residents being exposed to very serious health effects.

  • Kinder Morgan’s own estimate is that pipeline leaks under 75 litres per hour may not be detected.

While I find the presentation’s hysteria a little off-putting, it did alert me to one or two new issues, benzene gas and when spillage from the pipes raises an alarm. For anyone curious about benzene gas and other chemical aspects of an oil spill, there’s a US National Oceanic and Atmospheric Administration (NOAA) webpage titled, Chemistry of an Oil Spill.

Getting back to the pipes, that figure of 75 litres per hour puts a new perspective on the proposed Abakan solution and it suggests that whether or not more and bigger pipes are in our future, we should do a better of job of protecting our environment now. That means better cladding for the pipes and better dispersants and remediation for water, earth, air when there’s a spill.

Nanocellulose markets report released

I don’t usually feature reports about market conditions as this information lies far outside my understanding. In other words, this post is not an endorsement. However, as I often feature information on nanocellulose and, less frequently, on efforts of commercialize it, this June 3, 2015 news item on Azonano is being added here to provide a more complete picture of the ‘nanocellulose scene’,

The report “Nanocellulose Market by Type (Cellulose nanocrystals [aka nanocellulose nanocrystals {NCC} or {CNC}], Cellulose nanofibrils [CNF], cellulose nanocomposites, and others), Application (Composites and Packaging, Paper and Paper Board, Biomedicine, Rheology Modifier, Flexible Electronics and Sensors, and Others), and Geography – Regional Trends & Forecast to 2019″ published by MarketsandMarkets, Nanocellulose Market is projected to register a market size in terms of value of $250 Million by 2019, signifying firm annualized CAGR [compound annual growth rate] of 19% between 2014 and 2019.

Here’s more from the MarketsandMarkets undated news release,

Early buyers will receive 10% customization on reports.

Nanocellulose market is projected to register a market size in terms of value of $250 Million by 2019, signifying firm annualized CAGR of 19% between 2014 and 2019.

The report also identifies the driving and restraining factors for nanocellulose market with an analysis of drivers, restraints, opportunities, and strengths. The market is segmented and the value has been forecasted on the basis of important regions, such as Asia-Pacific, North America, Europe, and Rest of the World (RoW). Further, the market is segmented and the demand and value are forecasted on the basis of various key applications of nano cellulose, such as composites and packaging, paper and paper board, biomedicine, and other applications.

Rising demand for technological advancements in end-user industries is driving the nanocellulose market

The application of nano cellulose [sic for all instances] in the end-user industries is witnessing a revolutionary change mainly due to the commercial development of nano cellulose driven by the increasing petroleum prices and the high-energy intensity in the production of chemicals and synthetic polymers. Nano cellulose is being developed for the novel use in applications ranging from scaffolds in tissue engineering, artificial skin and cartilage, wound healing, and vessel substitutes to biodegradable food packaging.

The nano cellulose is considered as a viable alternative to the more expensive high tech materials such as carbon fibers and carbon nanotubes. Since nano cellulose is made from tightly packed array of needle like crystals, it becomes incredibly tough. This makes it perfect for building future body armors that are both strong and light. Nano cellulose is also being used to make ultra-absorbent aerogels, fuel efficient cars, biofuel, and many more. Nano cellulose has also been used as a tablet binder in the pharmaceutical companies, with gradual increasing applications in tampons, advance wound healing, and developing a vital role in existing healthcare products.

North America is projected to drive the highest demand for nano cellulose in its end-user industries by 2020 [sic]

North America is the largest market for nano cellulose currently and the same is expected to continue till 2019. This is because of continuous technological innovations, advancements in healthcare industry, and rising focus on biodegradable food packaging. Europe market is expected to register second highest growth rate after North America. The Asia-Pacific market is expected to show a steady growth rate but the market is currently lower than North America and Europe. The U.S. and European countries are projected to be the hub of nano cellulose manufacturing in the world and are projected to be the major consumers of nano cellulose by 2019.

You can find the report, published in April 2015, here.

New US platform for nanocellulose and occupational health and safety research

There’ve been quite a few (more than two) news items about nanocellulose in the last weeks. This latest one from the US National Institute for Occupational Safety and Health (NIOSH) concerns a memorandum of understanding (MOU) on a new research platform, from a May 28, 2015 news item on Nanowerk,

The National Institute for Occupational Safety and Health (NIOSH) has signed a memorandum of understanding (MOU) with the Partnership to Advance Research and Guidance for Occupational Safety and Health in Nanotechnology (P3NANO). The partnership between NIOSH and P3NANO will serve as a platform for occupational safety and health research as well as educational and business initiatives leading to the development of new risk management guidance, recommendations, and findings relating to the potential human health impacts of exposure to nanoscale cellulose materials.

I found more information about P3NANO in a Sept. 27, 2014 post by Michael Goergen for the Forest Business Network blog,

The U.S. Endowment for Forestry and Communities (Endowment) today announced the selection of nine scientific proposals designed to advance the commercialization of Cellulosic Nanomaterials (CN). The projects are being funded through P3Nano – a public-private partnership founded by the Endowment and the USDA Forest Service (USFS) with federal matching funds being provided by the Forest Service’s State and Private Forestry and Research and Develop branches and work coordinated with the USFS Forest Products Laboratory. The initial projects total more than $3 million in partnership funding.

Through a review process that included experts in business, government, and academia with extensive experience in CN, proposals were selected from 65 submissions requesting more than $20 million.

Carlton Owen, Chair of the P3Nano Steering Committee and President of the Endowment stated, “Our partnership is committed to finding new high-value products that build on the renewability of the nation’s forests. Cellulosic nanomaterials offer the promise of not only advanced green products for a more sustainable future but they do so while putting Americans to work in family-wage jobs at the same time that we advance the health and vitality of forests.”

P3Nano had previously awarded its foundational grant focusing on the environmental health and safety of cellulosic nanomaterials ensuring that priority one is the understanding of the environmental impacts and public safety.

The P3Nano (P3NANO) partnership does not seem to have its own website but there is this webpage on the US Endowment for Forestry & Communities, Inc.

One final comment, I’m surprised this initiative didn’t make the list published by the US White House of its new initiatives to commercialize nanotechnology (see my May 27, 2015 post for a full list).

US White House establishes new initiatives to commercialize nanotechnology

As I’ve noted several times, there’s a strong push in the US to commercialize nanotechnology and May 20, 2015 was a banner day for the efforts. The US White House announced a series of new initiatives to speed commercialization efforts in a May 20, 2015 posting by Lloyd Whitman, Tom Kalil, and JJ Raynor,

Today, May 20 [2015], the National Economic Council and the Office of Science and Technology Policy held a forum at the White House to discuss opportunities to accelerate the commercialization of nanotechnology.

In recognition of the importance of nanotechnology R&D, representatives from companies, government agencies, colleges and universities, and non-profits are announcing a series of new and expanded public and private initiatives that complement the Administration’s efforts to accelerate the commercialization of nanotechnology and expand the nanotechnology workforce:

  • The Colleges of Nanoscale Science and Engineering at SUNY Polytechnic Institute in Albany, NY and the National Institute for Occupational Safety and Health are launching the Nano Health & Safety Consortium to advance research and guidance for occupational safety and health in the nanoelectronics and other nanomanufacturing industry settings.
  • Raytheon has brought together a group of representatives from the defense industry and the Department of Defense to identify collaborative opportunities to advance nanotechnology product development, manufacturing, and supply-chain support with a goal of helping the U.S. optimize development, foster innovation, and take more rapid advantage of new commercial nanotechnologies.
  • BASF Corporation is taking a new approach to finding solutions to nanomanufacturing challenges. In March, BASF launched a prize-based “NanoChallenge” designed to drive new levels of collaborative innovation in nanotechnology while connecting with potential partners to co-create solutions that address industry challenges.
  • OCSiAl is expanding the eligibility of its “iNanoComm” matching grant program that provides low-cost, single-walled carbon nanotubes to include more exploratory research proposals, especially proposals for projects that could result in the creation of startups and technology transfers.
  • The NanoBusiness Commercialization Association (NanoBCA) is partnering with Venture for America and working with the National Science Foundation (NSF) to promote entrepreneurship in nanotechnology.  Three companies (PEN, NanoMech, and SouthWest NanoTechnologies), are offering to support NSF’s Innovation Corps (I-Corps) program with mentorship for entrepreneurs-in-training and, along with three other companies (NanoViricides, mPhase Technologies, and Eikos), will partner with Venture for America to hire recent graduates into nanotechnology jobs, thereby strengthening new nanotech businesses while providing needed experience for future entrepreneurs.
  • TechConnect is establishing a Nano and Emerging Technologies Student Leaders Conference to bring together the leaders of nanotechnology student groups from across the country. The conference will highlight undergraduate research and connect students with venture capitalists, entrepreneurs, and industry leaders.  Five universities have already committed to participating, led by the University of Virginia Nano and Emerging Technologies Club.
  • Brewer Science, through its Global Intern Program, is providing more than 30 students from high schools, colleges, and graduate schools across the country with hands-on experience in a wide range of functions within the company.  Brewer Science plans to increase the number of its science and engineering interns by 50% next year and has committed to sharing best practices with other nanotechnology businesses interested in how internship programs can contribute to a small company’s success.
  • The National Institute of Standards and Technology’s Center for Nanoscale Science and Technology is expanding its partnership with the National Science Foundation to provide hands-on experience for students in NSF’s Advanced Technology Education program. The partnership will now run year-round and will include opportunities for students at Hudson Valley Community College and the University of the District of Columbia Community College.
  • Federal agencies participating in the NNI [US National Nanotechnology Initiative], supported by the National Nanotechnology Coordination Office [NNCO], are launching multiple new activities aimed at educating students and the public about nanotechnology, including image and video contests highlighting student research, a new webinar series focused on providing nanotechnology information for K-12 teachers, and a searchable web portal on nano.gov of nanoscale science and engineering resources for teachers and professors.

Interestingly, May 20, 2015 is also the day the NNCO held its second webinar for small- and medium-size businesses in the nanotechnology community. You can find out more about that webinar and future ones by following the links in my May 13, 2015 posting.

Since the US White House announcement, OCSiAl has issued a May 26, 2015 news release which provides a brief history and more details about its newly expanded NanoComm program,

OCSiAl launched the iNanoComm, which stands for the Integrated Nanotube Commercialization Award, program in February 2015 to help researchers lower the cost of their most promising R&D projects dedicated to SWCNT [single-walled carbon nanotube] applications. The first round received 33 applications from 28 university groups, including The Smalley-Curl Center for Nanoscale Science and Technology at Rice University and the Concordia Center for Composites at Concordia University [Canada] among others. [emphasis mine] The aim of iNanoComm is to stimulate universities and research organizations to develop innovative market products based on nano-augmented materials, also known as clean materials.

Now the program’s criteria are being broadened to enable greater private sector engagement in potential projects and the creation of partnerships in commercializing nanotechnology. The program will now support early stage commercialization efforts connected to university research in the form of start-ups, technology transfers, new businesses and university spinoffs to support the mass commercialization of SWCNT products and technologies.

The announcement of the program’s expansion took place at the 2015 Roundtable of the US NanoBusiness Commercialization Association (NanoBCA), the world’s first non-profit association focused on the commercialization of nanotechnologies. NanoBCA is dedicated to creating an environment that nurtures research and innovation in nanotechnology, promotes tech-transfer of nanotechnology from academia to industry, encourages private capital investments in nanotechnology companies, and helps its corporate members bring innovative nanotechnology products to market.

“Enhancing iNanoComm as a ‘start-up incubator’ is a concrete step in promoting single-wall carbon nanotube applications in the commercial world,” said Max Atanassov, CEO of OCSiAl USA. “It was the logical thing for us to do, now that high quality carbon nanotubes have become broadly available and are affordably priced to be used on a mass industrial scale.”

Vince Caprio, Executive Director of NanoBCA, added that “iNanoComm will make an important contribution to translating fundamental nanotechnology research into commercial products. By facilitating the formation of more start-ups, it will encourage more scientists to pursue their dreams and develop their ideas into commercially successful businesses.”

For more information on the program expansion and how it can reduce the cost of early stage research connected to university projects, visit the iNanoComm website at www.inanocomm.org or contact info@inanocomm.org.

h/t Azonano May 27, 2015 news item

Large(!)-scale graphene composite fabrication at the US Oak Ridge National Laboratory (ORNL)

When you’re talking about large-scale production of nanomaterials, it would be more accurate term to say ‘relatively large when compared to the nanoscale’. A May 15, 2015 news item on ScienceDaily, trumpets the news,

One of the barriers to using graphene at a commercial scale could be overcome using a method demonstrated by researchers at the Department of Energy’s Oak Ridge National Laboratory [ORNL].

Graphene, a material stronger and stiffer than carbon fiber, has enormous commercial potential but has been impractical to employ on a large scale, with researchers limited to using small flakes of the material.

Now, using chemical vapor deposition, a team led by ORNL’s Ivan Vlassiouk has fabricated polymer composites containing 2-inch-by-2-inch sheets of the one-atom thick hexagonally arranged carbon atoms. [emphasis mine]

Once you understand where these scientists are coming from in terms of the material size, it becomes easier to appreciate the accomplishment and its potential. From a May 14, 2015 ORNL news release (also on EurekAlert), which originated the news item,

The findings, reported in the journal Applied Materials & Interfaces, could help usher in a new era in flexible electronics and change the way this reinforcing material is viewed and ultimately used.

“Before our work, superb mechanical properties of graphene were shown at a micro scale [one millionth of a metre],” said Vlassiouk, a member of ORNL’s Energy and Transportation Science Division. “We have extended this to a larger scale, which considerably extends the potential applications and market for graphene.”

While most approaches for polymer nanocomposition construction employ tiny flakes of graphene or other carbon nanomaterials that are difficult to disperse in the polymer, Vlassiouk’s team used larger sheets of graphene. This eliminates the flake dispersion and agglomeration problems and allows the material to better conduct electricity with less actual graphene in the polymer.

“In our case, we were able to use chemical vapor deposition to make a nanocomposite laminate that is electrically conductive with graphene loading that is 50 times less compared to current state-of-the-art samples,” Vlassiouk said. This is a key to making the material competitive on the market.

If Vlassiouk and his team can reduce the cost and demonstrate scalability, researchers envision graphene being used in aerospace (structural monitoring, flame-retardants, anti-icing, conductive), the automotive sector (catalysts, wear-resistant coatings), structural applications (self-cleaning coatings, temperature control materials), electronics (displays, printed electronics, thermal management), energy (photovoltaics, filtration, energy storage) and manufacturing (catalysts, barrier coatings, filtration).

Here’s a link to and a citation for the paper,

Strong and Electrically Conductive Graphene-Based Composite Fibers and Laminates by Ivan Vlassiouk, Georgios Polizos, Ryan Cooper, Ilia Ivanov, Jong Kahk Keum, Felix Paulauskas, Panos Datskos, and Sergei Smirnov. ACS Appl. Mater. Interfaces, Article ASAP DOI: 10.1021/acsami.5b01367 Publication Date (Web): April 28, 2015

Copyright © 2015 American Chemical Society

This paper is behind a paywall.

May 20, 2015 free webinar for small- to medium-size nantoechnology businesses

The May 20, 2015 webinar is the second in a series being offered through the auspices of the US National Nanotechnology Coordination Office (NNCO). Here’s more from the NNCO May ?, 2015 announcement (h/t May 7, 2015 Nanowerk news item),

The National Nanotechnology Coordination Office (NNCO) will hold the second in a series of free webinars focusing on the experiences, successes, and challenges for small- and medium-sized nanotechnology businesses and on issues of interest to the nanotechnology business community on Wednesday May 20, 2015 from 2-3pm EDT.

Who/Speakers:
Speakers at the event will include:

  • Dr. Ajay P. Malshe, Founder, Executive Vice President, and CTO of NanoMech.  NanoMech has developed patented platform nanotechnology innovations in machining and manufacturing, lubrication and energy, adaptive chemistries for advanced textile coatings, metal surface coatings, biomedical implant coatings, and strategic military applications.
  • Dr. Matthew Putnam, CEO of Nanotronics Imaging. Nanotronics Imaging uses a convergence in computational processing, automation, and artificial intelligence algorithms to image and analyze materials at the nanoscale for development of new semiconconductors, medical devices, regenerative organs, and photovoltaics.

Who/Viewers:   Members of the small- and medium-sized nanotechnology business community, as well as interested members of the general public, media, academia, industry, NGOs, and Federal, state, and local governments are encouraged to participate.

Why:  To engage in a dialogue about topics of interest to the small- and medium-sized nanotechnology business community through a free, online format. These webinars will inform topics for subsequent webinars for the SME community over the course of the year.

How:  Invited speakers will begin the event by providing an overview of their experiences, successes, and challenges in the nanotechnology SME space. This will be followed by a Q&A segment with members of the public. Questions for the panel can be submitted to webinar@nnco.nano.gov from now through the end of the webinar at 3pm on May 20, 2015.

Registration:  This webinar is free and open to the public with registration on a first-come, first-served basis. Click here to register now. Registration will be capped at 200 people. For those unable to watch the event live, the webcast, including closed captioning, will be posted on Nano.gov following the event.

Contact Us:
Direct Link: Nano.gov/SMEwebinars2015
Twitter: #SMEwebinars2015
Email: webinar​@nnco.nano.gov

For the curious, there are a few more details in my Jan. 7, 2015 posting announcing the first in the series.

Queen’s University (Canada) opens Kingston Nano-Fabrication Lab (KNFL)

First, there’s the opening (from an April 24, 2015 Queen’s University news release; Note: A link has been removed),

Queen’s University has secured its place at the forefront of transforming innovative research with the opening of the Kingston Nano-Fabrication Laboratory (KNFL).

The laboratory, located at Innovation Park, represents a milestone in the 30-year collaboration between Queen’s and CMC Microsystems for advancing Canadian strength in micro-nano innovation.

Some interesting details about the deal and the proposed uses for KNFL can be found in an April 24, 2015 story by Colleen Seto for Canada Foundation for Innovation (CFI),

… a brand-new, 3,000-square-foot, $5 million research facility [KNFL] located at the Queen’s University Innovation Park. The lab includes $2.5 million in new CFI-funded custom equipment for fabricating and prototyping new nano-scale inventions to get them to market quicker.

“We’re making devices, films, coatings, and materials, and examining their properties at the nanoscale,” says Ian McWalter, President and CEO of CMC Microsystems, which manages the operations of KNFL. “This fundamental materials research spills over into experiments of great use to industry, which then looks at how to commercialize he research results.”

The Queen’s University news release describes the longstanding relationship between the company managing the KNFL and the university,

“This facility is the latest manifestation of a long and productive relationship between Queen’s and CMC Microsystems,” says Ian McWalter, president and CEO of CMC. “For more than three decades, this partnership has enabled research and advanced training activities nationwide that would not have otherwise occurred. The KNFL is a significant enhancement, and we look forward to exploring the expanded opportunities that it offers us for building Canadian strength in micro-nano research and innovation.”

The CFI story provides more specifics about the potential workings of the facility,

Take, for example, the possibilities presented by KNFL’s laser micromachining system. “This new tool could be used to engrave channels into a piece of glass or polymer to produce a microfluidic device,” says Andrew Fung, Client Technology Advisor for Microsystems and Nanotechnology at CMC. Microfluidic devices take advantage of the behaviour of fluids at a very small scale to create things like “lab-on-a-chip” technologies that can be used to cheaply and quickly diagnose diseases in developing countries, among many other things. “Microfluidics grew out of silicon-based fabrication, which costs a lot of money,” explains Fung. “These other materials are lower cost, and can be single use, consumable, and disposable for a medical device.”

Much of KNFL’s new equipment was selected to enable rapid prototyping of new nanotechnologies. “Prototypes can be ready within hours or a day, instead of days or weeks. It shortens the whole innovation process so researchers can design, make, test, and get the information they need much faster,” says Fung.

The CFI story also contextualizes this project by noting that it’s part of a larger initiative,

The KNFL is also part of Embedded Systems Canada (emSYSCAN), a $50-million, five-year project aimed at shortening the microsystems development cycle. It involves more than 350 university researchers at 37 institutions across Canada’s National Design Network (NDN), which enables multidisciplinary research and collaboration through shared technologies and expertise.

The KNFL’s open-access model is aimed specifically at supporting the NDN. “The idea is to make [expertise and tools] more available to non-experts and to overcome barriers such as lab training to access this equipment,” says McWalter. “Through the service aspect of our lab, you wouldn’t necessarily twiddle the knobs yourself, but you would contract the lab to do things for you.” This provides vital learning opportunities for students while giving researchers a more efficient means to an end — accessing the equipment they need without having to invest the time and effort to learn how to use it.

Congratulations to the folks at Queen’s University!

Partners wanted to commercialize new production technique for metallic nanoparticles

An April 20, 2015 news item on Azonano announces a new technique for producing metallic nanoparticles (Note: A link has been removed),

Researchers at VTT Technical Research Centre of Finland Ltd have devised a new, inexpensive metallic nanoparticle manufacturing technique.

The aerosol technology reactor employed for nanoparticle synthesis is capable of producing carbon-coated particles, particles of various alloys and a number of pure metal particles. It can even produce several grams and kilograms of nanoparticles every day.

Nanoparticles are suitable for applications including energy technology, tailoring the electrical and magnetic properties of polymers, drug dosing and medical diagnostics, and conductive and magnetic inks. VTT is looking forward to commercialize the technique.

An April 20, 2015 VTT press release (also on EurekAlert), which originated the news item,  describes the project’s achievements in more detail and makes a plea (of sorts) for partners to commercialize this work,

“Demand has outstripped supply in the nanoparticle markets. This has been an obstacle to the development of product applications; nano-metal composites are scarce and often available in small quantities only. We wanted to demonstrate that it was possible to produce nanomaterials in considerable quantities cost-effectively,” comments Ari Auvinen of VTT, head of the research team.

When developing the reactor, the aim was to achieve a production figure of 200-3,000 grammes per day. This has already been clearly exceeded. Due to the extremely small material wastage incurred when using this equipment, remote-control production can be maintained for several days. In most cases, industrial production of metallic nanoparticles involves chemical reduction in liquid solutions, which requires the design of product-specific solutions. Plasma synthesis, which consumes large amounts of energy and involves significant material wastage, is another generally used method.

In the design of the reactor developed by VTT, the scalability and cost-effectiveness of the synthesis process were key criteria. For this reason, synthesis is performed under air pressure at a comparatively low temperature. This means that the equipment can be built from materials commonly used in industry and energy consumption is low. The process generates an extremely high particle concentration, enabling a high production speed but with low gas consumption. In addition, even impure metallic salts can be used as a raw material, which keeps the price low.

VTT has demonstrated the practical functionality of its reactor by testing the production of various nanometals, metallic compounds and carbon-coated materials. Materials such as carbon-coated magnets, which can be used as catalysts in biorefineries – say, in the production of biofuels – have been produced in the reactor. Following synthesis, magnets used as catalysts can be efficiently gathered in and recycled back into the process.

Nanoparticles have also been tested in the manufacture of magnetic inks and inks that conduct electricity in printed electronics. For example, VTT succeeded in using a permalloy ink to print a magnetically anisotropic material, which can be used in the manufacture of magnetic field sensors.

VTT’s third application trial involved the prevention of microwave reflection. The tests showed that reflection can be reduced by even 10,000 times in polymers, by adding particles which increase radar wave attenuation.

VTT’s researchers believe that the reactor has many applications in addition to those already mentioned. The silicon nanoparticles it produces may even enable lithium battery capacity to be boosted by a factor of 10. Other possible applications, all of which require further investigation, include high permeability polymers, nanomagnets for medical diagnostics applications, materials for the 3D printing of metal articles, and silicon-based materials for thermoelectric and solar power components.

VTT is currently seeking a party interested in commercialising the technique.

For interested parties, here is the contact information listed in the press release,

For more information, please contact:

Raimo Korhonen, Head of Research Area
tel. +358 40 7030052, raimo.korhonen@vtt.fi

Good luck!

Canada’s cannabis biotech and InMed Pharma’s nanoparticle-based drug delivery system grant

Unfortunately, there’s not much detail about the nanoparticle-based drug delivery of what I gather is a form of cannabis useful in the treatment of glaucoma in this April 16, 2015 news item on Azonano,

InMed Pharmaceuticals Inc., a clinical stage biopharmaceutical company that specializes in developing safer, more effective cannabinoid-based therapies, today announced that it has been awarded a grant to further develop the Company’s proprietary nanoparticle-based delivery system for their leading drug candidate CTI-085 for glaucoma.

An April 15, 2015 InMed Pharmaceuticals press release goes on to describe the lead researcher and her past experience, as well as, providing a ‘we’re thrilled and will do wonderful things with this money’ quote,

The Mitacs grant was awarded to Dr. Maryam Kabiri, Ph.D., a researcher with extensive experience in developing nanoparticle-based delivery system. Dr. Kabiri will be working with Prof. Vikramaditya G. Yadav, whose research focuses on metabolic & enzyme engineering and customize novel biosynthetic enzymes that can convert biomass-derived feedstock into better fuels, pharmaceuticals and value-added chemicals. In conjunction with InMed, the Mitacs grant will be utilized to develop a novel delivery system for glaucoma therapy.

Dr. Sazzad Hossain, Chief Scientific Officer, states, “We are pleased to have met the Mitacs funding criteria for the advancement of our proprietary glaucoma delivery system. Not only does this bring us closer to our goals of initiating our Phase 1 trial, but it furthers our business development strategy of having a proprietary delivery system that can be licensed with existing drugs endangered by patent expiration. This “therapy extension” strategy used by drug makers can be a valuable asset to InMed upon successful completion of the program. Additionally, the incorporation of an existing medicine into a new drug delivery system can significantly improve its performance in terms of efficacy, safety, and improved patient compliance.”

About Mitacs
Mitacs is a national, private not-for-profit organization that develops the next generation of innovators with vital scientific and business skills through a suite of unique research and training programs, such as Mitacs-Accelerate, Elevate, Step, Enterprise and Globalink. In partnership with companies, government and universities, Mitacs is supporting a new economy using Canada’s most valuable resource – its people.

For more information on Mitacs, visit www.mitacs.ca.

About InMed
InMed is a clinical stage biopharmaceutical company that specializes in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMeds’ proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the Company.

As is becoming increasingly common, there’s a major focus on business even from Dr. Sazzad Hossain, the company’s chief scientific officer who might be expected to comment on the science. Business used to be the purview of the chief executive officer, the chief financial officer, the chief operating officer,  and/or the chief marketing officer.

I did manage to dig up a bit of information about InMed which was called Cannabis Technologies until fairly recently. Daniel Cossins in a Dec. 1, 2014 article for The Scientist describes the current ‘cannabis pharmaceutical’ scene. The dominant  player on the scene is a UK-based company, GW but InMed merits a mention,

Leading scientists were consulted, including  biotech entrepreneur Geoffrey Guy, who had  previously shown interest in developing cannabis-based medicines. The government granted Guy’s company, GW Pharmaceuticals, a license to grow cannabis plants. Guy’s idea was to generate strains rich in particular cannabinoid compounds that act on the nervous system, then test the effects of various cannabinoid combinations on MS and chronic pain. “It was a case of patient experience guiding scientific exploration,” says Stephen Wright, director of research and development at GW.

In 2010, the company announced the UK launch of its first cannabinoid-based product: Sativex, an oral spray for the treatment of MS spasticity, became the world’s first prescription medicine made from cannabis extracts. Sativex is now approved for use by MS patients in 24 countries, including France, Germany, Italy, and Australia. GW has partnered with Bayer and Novartis to market the  product. It has also signed up with the American branch of Japanese pharma company Otsuka to commercialize the drug in the U.S., where it is currently in Phase 3 clinical trials for treating MS spasticity and cancer pain. Earlier this year, GW’s share price surged when the US Food and Drug  Administration (FDA) granted orphan status to its cannabis-derived antiseizure drug Epidiolex, meaning it will be fast-tracked through clinical trials.

The company’s success is blazing a trail. In recent years, a handful of North American companies have set out on a similar path toward producing cannabis-derived pharmaceuticals. At least one company is developing candidates based on synthetic cannabinoids — of which two are already on the market in the U.S. — while several others are extracting chemical cocktails from the plant. They’re all hoping to capitalize on the anticipated growth of the cannabis pharma space by taking advantage of mounting data on the plant’s therapeutic effects.

“Frankly, we looked at GW and saw that the shift toward pharmacological development of marijuana is  already happening,” says Craig Schneider, president and CEO of InMed Pharmaceuticals (formerly Cannabis Technologies), a Vancouver-based biotech focused on pharmaceutical marijuana. “We see the likes of Otsuka, Novartis, and Eli Lilly diving into the space, and we want to be part of that.”

Cossins’ article goes on to discuss cannibinoids providing a tutorial of sorts on the topic. Meanwhile following on the business aspects of this story, Yahoo Finance  hosts a June 25, 2014 article from Accesswire, which provides some insight into the company, which was still being called Cannabis Technologies, and its GW aspirations,

 Cannabinoids are a diverse set of chemical compounds that act on cannabinoid receptors on cells that repress neurotransmitter release in the brain. While tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”) are the two most popular cannabinoids, there are at least 85 different cannabinoids isolated from cannabis exhibiting various effects that could prove therapeutic.

GW Pharmaceuticals plc (GWPH), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid platform, has become the cannabinoid industry’s poster child with a ~$1.4 billion market capitalization and promising data from the clinic for the treatment of Dravet syndrome and Lennox-Gastaut syndrome.

In this article, we’ll take a look at another opportunity in the sector that many are calling the “junior GW” [InMed Pharma, formerly Cannabis Technologies], focused on leveraging its proprietary Cannabinoid Drug Design Platform to rapidly develop cannabinoid-based therapies.

Fully Integrated Platform Play

Cannabis Technologies Inc. (CSE:CAN) (CANLF) is a biopharmaceutical drug discovery and development company focused on cannabinoids that has been dubbed by many as the “Junior GW” in the space. By leveraging its proprietary Cannabinoid Drug Design Platform, management aims to identify new bioactive compounds within the marijuana plant that interact with certain genes.

According to Chief Science Officer Sazzad Hossain, the platform provides the bioinformatics tools necessary to isolate and identify chemical compounds in medical marijuana in months instead of years. The company plans to use the platform to isolate compounds targeting a specific disease and then outsource the early-stage research and trials to get to Phase I quickly and inexpensively.

The company’s initial focus is on the $12 billion ocular diseases market, including the $5.7 billion glaucoma market, where its CTI-085 is preparing to undergo Phase I clinical trials shortly after having completing preclinical trials. In addition to these areas, management also expressed interest in larger market places like pain and inflammation, as well as orphan diseases, cancers, and metabolic diseases.

Similar to GW Pharmaceuticals, the company also operates a breeding and cultivation division that’s responsible for creating its medicines in-house. The proprietary phyto-stock produced by the division sets the firm apart from some of its competitors that rely on third-parties to manufacture their treatments, since the fully-integrated operations are often both lower cost and greater quality.

They certainly have high business hopes for InMed Pharma. As for the science, the company has a Cannabinoid Science webpage on its site,

The majority of pharmaceutical and academic research & development being performed with cannabis revolves around the understanding of its active ingredients, the Cannabinoids

Currently there are between 80-100 cannabinoids that have been isolated from cannabis, that affect the body’s cannabinoid receptors and are responsible for unique pharmacological effects.

There are three general types of cannabinoids: herbal cannabinoids which occur uniquely in the cannabis; endogenous cannabinoids produced in the bodies of humans and animals and synthetic cannabinoids produced in the laboratory.

I was not able to find anything about the company’s nanoparticle-based delivery system on its website.